ONEVIEW HEALTHCARE PLC (ONE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ONE - ONEVIEW HEALTHCARE PLC

FNArena Sector : Medical Equipment & Devices

Year End: December

GICS Industry Group : Health Care Equipment & Services

Debt/EBITDA: -0.11

Index: ALL-ORDS

LAST PRICE	CHANGE +/-	CHANGE %	VOLUME
$0.275 29 Apr 2025	-0.005 OPEN $0.28	-1.79% HIGH $0.29	327,203 LOW $0.27

TARGET

$0.45

63.6% upside

OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . AYA . BB1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CVB . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI .

FNARENA'S MARKET CONSENSUS FORECASTS

12 Month Avg FX Values

Present FX Values

Original Currency

Title	FY25 Forecast	FY26 Forecast
EPS (cps)	N/A	xxx
DPS (cps)	N/A	xxx
EPS Growth	N/A	xxx
DPS Growth	N/A	xxx
PE Ratio	N/A	xxx
Dividend Yield	0.0%	xxx
Div Pay Ratio(%)	N/A	xxx

Title	FY25 Forecast	FY26 Forecast
EPS (cps)	N/A	xxx
DPS (cps)	N/A	xxx
EPS Growth	N/A	xxx
DPS Growth	N/A	xxx
PE Ratio	N/A	xxx
Dividend Yield	0.0%	xxx
Div Pay Ratio(%)	N/A	xxx

Title	FY23 Actual	FY24 Actual	FY25 Forecast	FY26 Forecast
EPS (cps)	xxx	N/A	N/A	xxx
DPS (cps)	xxx	N/A	N/A	xxx
EPS Growth	xxx	N/A	N/A	xxx
DPS Growth	xxx	N/A	N/A	xxx
Div Pay Ratio(%)	xxx	N/A	N/A	xxx

This company reports in EUR.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

HISTORICAL DATA ARE ALL IN AUD

Copyright © 2025 FactSet UK Limited. All rights reserved

Title	2019	2020	2021	2022	2023	2024
EPS Basic	xxx	xxx	xxx	xxx	xxx	-2.6
DPS All	xxx	xxx	xxx	xxx	xxx	0.0
Sales/Revenue	xxx	xxx	xxx	xxx	xxx	16.2 M
Book Value Per Share	xxx	xxx	xxx	xxx	xxx	2.9
Net Operating Cash Flow	xxx	xxx	xxx	xxx	xxx	-17.2 M
Net Profit Margin	xxx	xxx	xxx	xxx	xxx	-109.52 %

EPS Basic

Negative
Growth
Slowing

DPS All

Negative
Growth
Slowing

Sales/Revenue

Negative
Growth
Slowing

Book Value Per Share

Negative
Growth
Slowing

Net Operating Cash Flow

Negative
Growth
Slowing

Net Profit Margin

Negative
Growth
Slowing

Title	2019	2020	2021	2022	2023	2024
Return on Capital Employed	xxx	xxx	xxx	xxx	xxx	-96.17 %
Return on Invested Capital	xxx	xxx	xxx	xxx	xxx	-89.47 %
Return on Assets	xxx	xxx	xxx	xxx	xxx	-45.05 %
Return on Equity	xxx	xxx	xxx	xxx	xxx	-96.17 %
Return on Total Capital	xxx	xxx	xxx	xxx	xxx	-92.23 %
Free Cash Flow ex dividends	xxx	xxx	xxx	xxx	xxx	-17.3 M

Return on Capital Employed

Negative
Growth
Slowing

Return on Invested Capital

Negative
Growth
Slowing

Return on Assets

Negative
Growth
Slowing

Return on Equity

Negative
Growth
Slowing

Return on Total Capital

Negative
Growth
Slowing

Free Cash Flow ex dividends

Negative
Growth
Slowing

Title	2019	2020	2021	2022	2023	2024
Short-Term Debt	xxx	xxx	xxx	xxx	xxx	0 M
Long Term Debt	xxx	xxx	xxx	xxx	xxx	2 M
Total Debt	xxx	xxx	xxx	xxx	xxx	2 M
Goodwill - Gross	xxx	xxx	xxx	xxx	xxx	-
Cash & Equivalents - Generic	xxx	xxx	xxx	xxx	xxx	23 M
Price To Book Value	xxx	xxx	xxx	xxx	xxx	10.09

Short-Term Debt

Negative
Growth
Slowing

Long Term Debt

Negative
Growth
Slowing

Total Debt

Negative
Growth
Slowing

Goodwill - Gross

Cash & Equivalents - Generic

Negative
Growth
Slowing

Price To Book Value

Negative
Growth
Slowing

Title	2019	2020	2021	2022	2023	2024
Capex	xxx	xxx	xxx	xxx	xxx	0.8 M
Capex % of Sales	xxx	xxx	xxx	xxx	xxx	4.65 %
Cost of Goods Sold	xxx	xxx	xxx	xxx	xxx	6 M
Selling, General & Admin. Exp & Other	xxx	xxx	xxx	xxx	xxx	29 M
Research & Development	xxx	xxx	xxx	xxx	xxx	17 M
Investments - Total	xxx	xxx	xxx	xxx	xxx	0 M

Capex

Negative
Growth
Slowing

Capex % of Sales

Negative
Growth
Slowing

Cost of Goods Sold

Negative
Growth
Slowing

Selling, General & Admin. Exp & Other

Negative
Growth
Slowing

Research & Development

Negative
Growth
Slowing

Investments - Total

Negative
Growth
Slowing

Negative

Growth

Slowing

EXPERT VIEWS
EXTRA COVERAGE

EXPERT VIEWS

Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Bell Potter	28/04/2025	1	Buy	$0.45	63.64%	Bell Potter highlights materially improved 1Q results for Oneview Healthcare, with cash receipts rising by circa 177.6% quarter-on-quarter, partly due to timing issues from the 4Q. The broker notes negotiations are underway with four prospective customers, including one of the top ten US health systems, for a commercial pilot scheduled to commence in August. The company is also preparing to implement its new Smart Terminal for a top-ten US hospital client in the June quarter and is targeting contract wins in Saudi Arabia and the UK during the second half of 2025, highlight the analysts. Bell Potter sees upside potential from operating leverage and a strong sales pipeline but retains conservative forecasts pending contract conversion milestones. Bell Potter retains its Buy rating and 45 cent target. FORECAST Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -1.00 cents. Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -0.50 cents.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Bell Potter

28/04/2025

Buy

$0.45

63.64%

Bell Potter highlights materially improved 1Q results for Oneview Healthcare, with cash receipts rising by circa 177.6% quarter-on-quarter, partly due to timing issues from the 4Q.

The broker notes negotiations are underway with four prospective customers, including one of the top ten US health systems, for a commercial pilot scheduled to commence in August.

The company is also preparing to implement its new Smart Terminal for a top-ten US hospital client in the June quarter and is targeting contract wins in Saudi Arabia and the UK during the second half of 2025, highlight the analysts.

Bell Potter sees upside potential from operating leverage and a strong sales pipeline but retains conservative forecasts pending contract conversion milestones.

Bell Potter retains its Buy rating and 45 cent target.

FORECAST
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -1.00 cents.
Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -0.50 cents.

Access Stockbroker Research History >

EXTRA COVERAGE

Display All Commentary

No. Of Recommendations

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
No data available in table

Access Extra Coverage Research History >

ONE STOCK CHART

FNArena News on ONE

1	FNArena Corporate Results Monitor – 27-02-2025 Feb 27 2025 - Australia

2	Health Is Wealth Jul 27 2022 - Australia

3	ASX Companies Adopt ESG Global Reporting Tool Jun 01 2021 - FYI

4	Telehealth: Part Of Healthcare Revolution May 12 2021 - Australia

5	FNArena Corporate Results Monitor Mar 01 2019 - Australia

Latest Medical Equipment & Devices News

1	ResMed’s Margin Expansion & Tariff Exemption Apr 28 2025 - Australia

2	Trend Remains Up For Catapult International Feb 18 2025 - Technicals

3	ESG Focus: Top ASX Companies, Superbugs & Hydrogen Feb 07 2025 - ESG Focus

4	ResMed Shakes Off GLP-1 Scare Feb 04 2025 - Australia

5	ResMed: Another Positive Quarterly Surprise? Jan 30 2025 - Australia

6	The Trend Remains Pro Medicus’ Friend Jan 16 2025 - Technicals

7	Diagnostic Imaging Radiates Opportunity Dec 18 2024 - Small Caps

8	ResMed’s Bounce-Back Complete Oct 29 2024 - Australia

9	Dr Boreham’s Crucible: Pro Medicus Sep 04 2024 - Australia

10	Pro Medicus: Don’t Stop Me Now Aug 20 2024 - Technicals

Dividend Yield Today On Last Actual Payout :	N/A
Estimated Dividend Growth (Average Of Past Three Years)	%
Amount Invested	$
Tell Me The Dividend After This Many Years

	Yield	Yield on investment
This Year
Year 1
Year 2
Year 3
Year 4
Year

Get 2 Weeks free trial

Sign Up

Member Login

ONEVIEW HEALTHCARE PLC (ONE)
Share Price Analysis and Chart